Christopher Vann
Chief Operating Officer bij AUTOLUS THERAPEUTICS PLC
Vermogen: 715 906 $ op 31-03-2024
Profiel
Christopher Vann is currently the Treasurer & Director at Alliance for Regenerative Medicine since 2023.
He is also the Chief Operating Officer & Senior Vice President at Autolus Therapeutics Plc since 2016.
Previously, he worked at Roche Holding AG as the Commercial Director from 1994 to 2016.
Mr. Vann completed his undergraduate degree at the School of Pharmacy.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
AUTOLUS THERAPEUTICS PLC
0.07% | 01-03-2023 | 112 211 ( 0.07% ) | 715 906 $ | 31-03-2024 |
Actieve functies van Christopher Vann
Bedrijven | Functie | Begin |
---|---|---|
AUTOLUS THERAPEUTICS PLC | Chief Operating Officer | 01-10-2016 |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Director/Board Member | 01-01-2021 |
Eerdere bekende functies van Christopher Vann
Bedrijven | Functie | Einde |
---|---|---|
ROCHE HOLDING AG | Corporate Officer/Principal | 01-09-2016 |
Opleiding van Christopher Vann
School of Pharmacy | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
ROCHE HOLDING AG | Health Technology |
AUTOLUS THERAPEUTICS PLC | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Health Services |